Literature DB >> 33778549

Interobserver Variability of Quantitative and Qualitative Assessment Using MRI in Malignant Pleural Mesothelioma.

Ritu R Gill1, David J Murphy1, Ravi T Seethamraju1, Emanuele Mazzola1, Raphael Bueno1, William G Richards1.   

Abstract

PURPOSE: To evaluate the interobserver variability associated with quantitative and qualitative MRI assessments of malignant pleural mesothelioma (MPM).
MATERIALS AND METHODS: Patients with MPM who underwent uniform-protocol preoperative MRI between 2009 and 2014 were included. The MRI-derived tumor volume was estimated. Unidimensional measurements of maximal pleural thickness (P max) and average pleural thickness (P avg) on axial MR images; maximal fissural thickness (F max); maximal diaphragmatic thickness (D max); and average diaphragmatic thickness (D avg) on sagittal reconstructed images were acquired. Interobserver agreement regarding the American Joint Committee on Cancer (AJCC) tumor stage at each criterion level was assessed by using Cohen κ statistics. Agreement between quantitative measurements was assessed by using Bland-Altman plots and intraclass correlation coefficients (ICCs).
RESULTS: The study cohort included 349 patients (median age, 68 years [age range, 30-90 years), 273 (78%) of whom were men and 203 (58%) of whom had epithelioid-subtype tumors. Qualitative assessment performed by using the AJCC staging criteria (eighth edition) was concordant in 31% of cases and yielded considerable disagreement (κ = 0.177). Inspection of the Bland-Altman plots led to decisive agreement between the two reviewers regarding MRI-derived tumor volume (ICC, 0.979). There was also a good degree of agreement between the two reviewers regarding unidimensional measurements of D max (ICC, 0.807), D avg (ICC, 0.823), P max (ICC, 0.787), P avg (ICC, 0.787), and F max (ICC, 0.659).
CONCLUSION: Quantitative assessment can enhance the clinical staging of MPM. Compared with qualitative assessment, quantitative assessment has low interobserver variability and could yield a tumor size criterion that is currently lacking in the AJCC clinical staging of MPM.Supplemental material is available for this article.© RSNA, 2020. 2020 by the Radiological Society of North America, Inc.

Entities:  

Year:  2020        PMID: 33778549      PMCID: PMC7977922          DOI: 10.1148/ryct.2020190066

Source DB:  PubMed          Journal:  Radiol Cardiothorac Imaging        ISSN: 2638-6135


  18 in total

Review 1.  Diagnosis, staging, and surgical treatment of malignant pleural mesothelioma.

Authors:  Michael Kent; David Rice; Raja Flores
Journal:  Curr Treat Options Oncol       Date:  2008-08-29

Review 2.  Confidence in Altman-Bland plots: a critical review of the method of differences.

Authors:  John Ludbrook
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-08-28       Impact factor: 2.557

Review 3.  Imaging of mesothelioma.

Authors:  Ritu R Gill
Journal:  Recent Results Cancer Res       Date:  2011

4.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.

Authors:  Terry K Koo; Mae Y Li
Journal:  J Chiropr Med       Date:  2016-03-31

5.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

6.  Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma.

Authors:  Marc de Perrot; Zhi Dong; Penelope Bradbury; Demetris Patsios; Shaf Keshavjee; Natasha B Leighl; Andrew Hope; Ronald Feld; John Cho
Journal:  Eur Respir J       Date:  2017-03-15       Impact factor: 16.671

Review 7.  Morphologic and functional imaging of malignant pleural mesothelioma.

Authors:  Masaki Yamamuro; Victor H Gerbaudo; Ritu R Gill; Francine L Jacobson; David J Sugarbaker; Hiroto Hatabu
Journal:  Eur J Radiol       Date:  2007-10-22       Impact factor: 3.528

8.  North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study.

Authors:  Ritu R Gill; David P Naidich; Alan Mitchell; Michelle Ginsberg; Jeremy Erasmus; Samuel G Armato; Christopher Straus; Sharyn Katz; Demetrois Patios; William G Richards; Valerie W Rusch
Journal:  J Thorac Oncol       Date:  2016-05-12       Impact factor: 15.609

9.  The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.

Authors:  Anna K Nowak; Kari Chansky; David C Rice; Harvey I Pass; Hedy L Kindler; Lynn Shemanski; Andrea Billé; Robert C Rintoul; Hasan F Batirel; Charles F Thomas; Joseph Friedberg; Susana Cedres; Marc de Perrot; Valerie W Rusch
Journal:  J Thorac Oncol       Date:  2016-09-26       Impact factor: 15.609

10.  Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma.

Authors:  Rob J van Klaveren; Joachim G J V Aerts; Hein de Bruin; Guiseppe Giaccone; Christian Manegold; Jan P van Meerbeeck
Journal:  Lung Cancer       Date:  2004-01       Impact factor: 5.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.